ChinaBio Today: The State of China Biotech – IPOs and M&A

ChinaBio Today -- Because of the worldwide financial downturn, business activity is shrinking almost universally, though some individual areas are demonstrating relative strength – and we think the life science industry in China is one of those areas. In this series of articles, ChinaBio® presents proprietary data developed by its own team of researchers that explains why we remain cautiously optimistic about China life science.

MORE ON THIS TOPIC